What Is Histatin 1? Definition and What Research Reports
Histatin 1 is a short, histidine-rich peptide secreted mainly by human salivary glands. In the published literature it is described as an endogenous human peptide studied in cell culture and animal models, where researchers have reported effects on cell adhesion, migration, wound closure, bone cell behaviour and inflammatory signalling. It is a research term, not an approved medicine, and this page summarises only what laboratory and preclinical studies have reported about it.
Definition
Histatin 1 (often written histatin-1 or Hst1) is a short, histidine-rich peptide produced by the human salivary glands and secreted into saliva. It belongs to the histatin family of cationic salivary peptides, which have historically been described in the oral-biology literature for their antifungal and antimicrobial properties. In more recent peptide research, histatin 1 is used mainly as a model of an endogenous human wound-associated peptide: a naturally occurring molecule that laboratory studies have examined for its effects on how cells attach to surfaces, migrate across a gap, and organise into tissue. Expression is not limited to salivary tissue — histatin-1 expression was also documented in human lacrimal (tear) gland epithelium in a 2016 study (PMID 26824896), which broadened the description of histatin 1 beyond saliva alone.
What Class of Molecule It Is
Histatin 1 is a peptide — a chain of amino acids far shorter than a full protein — characterised by a high histidine content and an overall positive charge at physiological pH. That cationic, histidine-rich character is the defining feature of the histatin family. Unlike synthetic research peptides designed in a laboratory, histatin 1 is endogenous: it is made by human tissue and is present in human secretions. Research groups typically work with synthesised or recombinant versions of the sequence so that concentration and purity can be controlled in cell and animal experiments.
Where the Term Appears
- Oral and salivary biology — the original context, where histatins are catalogued as constituents of human saliva.
- Wound-healing and regenerative research — studies of epithelial, endothelial and bone cell behaviour.
- Ophthalmic research — corneal and lacrimal epithelium models.
- Receptor and cell-biology research — work on how the peptide enters cells and what it binds.
How the Term Is Used in Peptide Research
In the literature, "histatin 1" usually refers to the specific human sequence rather than to a drug product. Papers use it as the applied agent in an in vitro assay — added to cultured cells at defined concentrations — or as a component loaded into a delivery material such as a hydrogel. A 2022 paper described a histatin-1-loaded adhesive and conductive biomolecular hydrogel constructed for diabetic wound models (PMID 35390401), which is an example of the peptide being treated as a payload within a biomaterial rather than as a free-standing injectable. Terminology in these papers is descriptive of experimental systems; none of the verified literature summarised here establishes a human therapeutic dose.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeWhat the Published Literature Reports
Cell adhesion, migration and angiogenesis
A 2017 study reported that the salivary peptide histatin-1 promoted endothelial cell adhesion, migration and angiogenesis in experimental models (PMID 28751526). Researchers examining human corneal epithelial cells reported effects of histatin-1 peptide on those cells in a 2017 report (PMID 28542418). These adhesion-and-migration findings are the most frequently repeated theme across the histatin 1 literature and underpin most of the wound-related work that followed.
Bone cells and bone repair
A 2021 paper characterised histatin-1 as a novel osteogenic factor that promoted bone cell adhesion, migration and differentiation in laboratory assays (PMID 33480156). A later 2023 study reported that the salivary peptide histatin-1 enhanced bone repair in vivo in an animal model (PMID 37562221). Taken together, these two reports describe a progression from cell-level observations to an animal repair endpoint, which is a common pattern in early preclinical peptide research.
Inflammation and macrophages
In macrophage work, the study reported that histatin-1 attenuated LPS-induced inflammatory signalling in RAW264.7 macrophages (PMID 34360629). A separate 2023 paper reported that human salivary histatin-1 attenuated osteoarthritis in an experimental model through promoting an M1-to-M2 macrophage transition (PMID 37111757). Both describe immunomodulatory rather than purely structural effects.
Diabetic and high-glucose wound models
Researchers reported that histatin-1 alleviated high-glucose injury to skin keratinocytes through the MAPK signalling pathway in a 2022 study (PMID 35819887). A 2024 paper reported that human salivary histatin 1 regulated IP3R1/GRP75/VDAC1-mediated mitochondria-associated endoplasmic reticulum membranes and inhibited cell senescence in a diabetic wound repair model (PMID 39343182).
Receptor binding and subcellular localisation
Mechanistic work has asked what histatin 1 binds and where it goes inside cells. A 2021 paper reported that histatin-1 is an endogenous ligand of the sigma-2 receptor (PMID 34233061). A 2020 study reported that salivary histatins 1 and 2 were targeted to mitochondria and the endoplasmic reticulum in human cells (PMID 32225006), which is consistent with the later mitochondria-associated membrane work.
Research Themes at a Glance
| Theme | Model type reported | Citation |
|---|---|---|
| Endothelial adhesion, migration, angiogenesis | Cell and experimental models | PMID 28751526 |
| Corneal epithelial cell effects | Human cell culture | PMID 28542418 |
| Bone cell adhesion and differentiation | Cell culture | PMID 33480156 |
| Bone repair | In vivo animal model | PMID 37562221 |
| Inflammatory signalling | RAW264.7 macrophages | PMID 34360629 |
| Diabetic wound / high glucose | Keratinocytes; wound models | PMID 35819887, PMID 39343182 |
| Receptor and localisation | Cell biology | PMID 34233061, PMID 32225006 |
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appSafety and Tolerability: What Studies Report
The verified literature summarised on this page consists of cell-culture experiments, biomaterial studies and animal models. These reports describe biological effects in those systems; they do not constitute human safety data, and no adverse-event profile in people can be drawn from them. Papers such as the hydrogel study (PMID 35390401) and the in vivo bone repair report (PMID 37562221) were conducted in preclinical settings, so their outcomes should be read as preclinical findings only. Histatin 1 is not an approved medicine, and materials sold under this name in research channels are typically labelled research-use-only.
Limitations of the Current Evidence
- Most published findings are in vitro or in small animal models, not controlled human trials.
- Concentrations used in cell culture do not translate directly to any systemic human exposure.
- Delivery matters: several reports used the peptide embedded in a hydrogel or applied topically rather than given systemically (PMID 35390401).
- Mechanistic work is still developing; sigma-2 receptor binding was described relatively recently (PMID 34233061).
This page is for educational purposes only and is not medical advice; consult a licensed physician about any health question or before making any decision related to a medical condition. Nothing here describes a protocol, and no dosing information for humans exists in the cited literature.
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeRelated Terminology
- Histatins — the wider family of histidine-rich salivary peptides that includes histatin 1, 3 and 5.
- Endogenous ligand — a naturally produced molecule that binds a receptor, as reported for histatin-1 and the sigma-2 receptor (PMID 34233061).
- MAMs — mitochondria-associated endoplasmic reticulum membranes, the subcellular contact sites examined in a 2024 diabetic wound study (PMID 39343182).
References
- Histatin-1 Attenuates LPS-Induced Inflammatory Signaling in RAW264.7 Macrophages (International Journal of Molecular Sciences, 2021)
- Histatin-1 loaded multifunctional, adhesive and conductive biomolecular hydrogel to treat diabetic wound (International Journal of Biological Macromolecules, 2022)
- Histatin-1 is an endogenous ligand of the sigma-2 receptor (The FEBS Journal, 2021)
- The salivary peptide histatin-1 enhances bone repair in vivo (Biochemical and Biophysical Research Communications, 2023)
- Human salivary histatin 1 regulating IP3R1/GRP75/VDAC1 mediated mitochondrial-associated endoplasmic reticulum membranes (MAMs) inhibits cell senescence for diabetic wound repair (Free Radical Biology & Medicine, 2024)
- Histatin-1 alleviates high-glucose injury to skin keratinocytes through MAPK signaling pathway (Journal of Cosmetic Dermatology, 2022)
- Histatin-1 Expression in Human Lacrimal Epithelium (PLoS One, 2016)
- Human Salivary Histatin-1 Attenuates Osteoarthritis through Promoting M1/M2 Macrophage Transition (Pharmaceutics, 2023)
- Effects of histatin-1 peptide on human corneal epithelial cells (PLoS One, 2017)
- Salivary Histatin 1 and 2 Are Targeted to Mitochondria and Endoplasmic Reticulum in Human Cells (Cells, 2020)
- Histatin-1 is a novel osteogenic factor that promotes bone cell adhesion, migration, and differentiation (Journal of Tissue Engineering and Regenerative Medicine, 2021)
- The salivary peptide histatin-1 promotes endothelial cell adhesion, migration, and angiogenesis (FASEB Journal, 2017)
Frequently asked questions
What is histatin 1 in simple terms?▾
Histatin 1 is a short, histidine-rich peptide made by human salivary glands and found in saliva. It is endogenous, meaning the body produces it naturally. Expression has also been documented outside saliva: a 2016 study reported histatin-1 expression in human lacrimal epithelium (PMID 26824896). In research it is studied mainly for its effects on cell adhesion and migration.
What have studies reported about histatin 1 and wound-related cells?▾
Researchers reported that histatin-1 promoted endothelial cell adhesion, migration and angiogenesis in experimental models (PMID 28751526), and a separate study reported effects of the peptide on human corneal epithelial cells (PMID 28542418). A 2022 report described histatin-1 alleviating high-glucose injury to skin keratinocytes through MAPK signalling (PMID 35819887). These were laboratory models, not human trials.
Does histatin 1 have a known receptor?▾
A 2021 paper reported that histatin-1 is an endogenous ligand of the sigma-2 receptor (PMID 34233061). Separately, a 2020 study reported that salivary histatins 1 and 2 were targeted to mitochondria and the endoplasmic reticulum in human cells (PMID 32225006). Mechanistic understanding is still developing, and these findings come from cell-level experiments.
Has histatin 1 been studied in bone research?▾
Yes. A 2021 study characterised histatin-1 as an osteogenic factor that promoted bone cell adhesion, migration and differentiation in cell assays (PMID 33480156). A 2023 report described the salivary peptide histatin-1 enhancing bone repair in vivo in an animal model (PMID 37562221). Both are preclinical; neither establishes any human application or dosing information.
What does the literature say about histatin 1 and inflammation?▾
The study on macrophages reported that histatin-1 attenuated LPS-induced inflammatory signalling in RAW264.7 cells (PMID 34360629). A 2023 paper reported that human salivary histatin-1 attenuated osteoarthritis in an experimental model by promoting an M1-to-M2 macrophage transition (PMID 37111757). These describe immunomodulatory behaviour in laboratory and animal systems only.
Is there human safety or dosing data for histatin 1?▾
The verified literature summarised here consists of cell-culture studies, biomaterial work such as a histatin-1-loaded hydrogel for diabetic wounds (PMID 35390401), and animal models (PMID 37562221). None of these provide a human dose or an established human adverse-event profile. Histatin 1 is not an approved medicine, and this information is educational, not medical advice.
How is histatin 1 usually delivered in studies?▾
Delivery varies by experiment. Many reports added synthesised peptide directly to cultured cells. Others embedded it in a material: a 2022 study described a histatin-1-loaded adhesive and conductive biomolecular hydrogel used in a diabetic wound model (PMID 35390401), and a 2024 paper examined histatin 1 in diabetic wound repair via mitochondria-associated ER membrane signalling (PMID 39343182).
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.